The Senate Finance Committee reported that 23 pharmaceutical companies provided nearly $1.47 billion in educational grants for CME activities in 2004—nearly a 20 percent increase over 2003.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva